Longeveron Inc. Subscription Right

YTD

ALL

Why Robinhood?

You can watch LGVNR and buy or sell other stocks, ETFs, and their options commission-free!

About LGVNR

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors.

CEO

Than Powell, MBA

CEOThan Powell, MBA

Employees

—

Employees—

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

2014

Founded2014

Employees

—

Employees—

LGVNR Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

The current Longeveron Inc. Subscription Right(LGVNR) stock price is $0.00.

On 2025-12-07, Longeveron Inc. Subscription Right(LGVNR) stock opened at —, reached a high of —, and a low of —.

The Longeveron Inc. Subscription Right(LGVNR)'s current trading volume is 0.